|
Volumn 29, Issue 4, 2009, Pages 317-318
|
Editorial: Antidepressants as hydrobromide salts: Are they a cause for concern?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BROMIDE ION;
BROMINE DERIVATIVE;
CHLORIDE;
CITALOPRAM;
HYDROBROMIDE SALT;
POTASSIUM BROMIDE;
SODIUM BROMIDE;
SODIUM CHLORIDE;
UNCLASSIFIED DRUG;
BROMIDE;
DRUG DERIVATIVE;
ACNE;
COMA;
DRUG SYNTHESIS;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HEADACHE;
INTOXICATION;
IRRITABILITY;
KIDNEY CLEARANCE;
KIDNEY DYSFUNCTION;
MEMORY DISORDER;
MENTAL INSTABILITY;
PRIORITY JOURNAL;
SEIZURE;
SLURRED SPEECH;
TABLET FORMULATION;
TREMOR;
DRUG INTERACTION;
DRUG LABELING;
HUMAN;
RISK ASSESSMENT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
BROMIDES;
BUPROPION;
CITALOPRAM;
DRUG INTERACTIONS;
DRUG LABELING;
HUMANS;
RISK ASSESSMENT;
|
EID: 68449100594
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/JCP.0b013e3181afe0f2 Document Type: Editorial |
Times cited : (4)
|
References (4)
|